Focus Stocks
JNJ - Above Average Volume Detected
Published on Friday, 15 June 2012 11:38 Written by TradersHuddle Wire
New York, June 15th (TradersHuddle.com) - Unusual high volume detected on shares of Johnson and Johnson (NYSE:JNJ) early in the trading session. The pace in volume of JNJ points to a break above average, with buyers stepping in, as the stock is 0.37% higher.
Johnson & Johnson (NYSE:JNJ) manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, Tylenol, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. The consumer healthcare products company was founded in 1886 and is based in New Brunswick, NJ.
JNJ has already traded 0.891 times its 3-month average volume and has calculated support and resistance at $61.71 and $66.32 respectively. Traders like to use volume as their lie detector for price action movement through predefined trading ranges.
The overall market index S&P 500 is trading higher by 0.59% from its previous trading close, which means that JNJ stock is underperforming the overall market.
Related Articles
- TradersHuddle Mid-day Update: Dow Jones Higher Top Performers: UNH, BAC, JPM
- Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
- Johnson & Johnson Announces Dividend Increase of 8.2%
- Johnson & Johnson to Host Pharmaceuticals Business Review
- Johnson & Johnson Announces Sale of Elan American Depositary Shares to Elan
- Worst Performing Dow Component: Bank of America
- Dow Jones Round Up - Higher: KO, JNJ, DIS
- Johnson & Johnson Reports 2013 First-Quarter Results:
- Johnson & Johnson to Webcast Annual Meeting of Shareholders
- Look And Feel Great This Spring, Despite Allergy Symptoms
Related Partner Headlines
- Tag Team: JNJ Dividend Trade - TheStreet.com
- New Phase 3 Findings Show STELARA® Significantly Reduced Signs and Symptoms of Active Psoriatic Arthritis - Benzinga
- A Great Dividend Is Not Enough - TheStreet.com
- Love Or Hate - Wall Street Will Love A Republican President (JNJ, UNH, WFC, BTU) - Investopedia
- Top Performing Dividend Payers in Health Care with the Most Upside Potential (TRIB, STE, CMN) - Benzinga
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Drugs Have Moved J&J On To A New Phase (JNJ, PFE, ABT, COV) - Investopedia
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Johnson & Johnson Rises 1% After Topping Estimates, Raising Guidance - Benzinga
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,387.58 Trade time:4:36PM EDT Value change:0.00 (0.00%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,669.16 Trade time:4:36PM EDT Value change:0.00 (0.00%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,502.12 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
Dividend Notice -
Medbox, Inc. Posts 1st Quarter 2013 Financials, Record Revenue Reported -
J.D. Power & Associates Reports: Insurance Websites Perform Better in Policy Servicing Than Policy Shopping -
Dais Analytic Corporation Shares Business Activities & Financial Data -
Quantum Technologies Announces Date of 2013 Annual Meeting of Stockholders -
Cloud Star Corp Joins the FIDO Fast Identity Online Alliance -
Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences -
LPS' "First Look" Mortgage Report: April Month-End Data Shows Delinquency Rate Below 6.5 Percent for First Time Since July 2008; Foreclosure Inventory Down Nearly 25 Percent Year-Over-Year








